Syneron Medical Ltd. 

(Public, NASDAQ:ELOS)   Watch this stock   
Find more results for ELOS
Nov 9, 2009
Q3 2009 Earnings Release
Sep 29, 2009
Maxim Group Conference
Sep 23, 2009
UBS Global Life Sciences Conference
Sep 9, 2009
Candela Corporation to Merge Conference Call - Webcast
More events from AOL Finance »    

Key stats and ratios

Q2 (Jun '09) 2008
Net profit margin -39.84% 4.89%
Operating margin -37.17% -1.56%
EBITD margin - 0.30%
Return on average assets -8.57% 2.04%
Return on average equity -9.48% 2.29%
Employees 300 -

Address

Industrial Zone P.O.B 550 Israel
Yokneam Illit, 20692
Israel
+972-4-9096200 (Phone)
+972-4-9096202 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

Syneron Medical Ltd. discussed on blogs

Ranking 1100+ Micro Cap Stocks by Upside Potential - NASD100.com ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Nov 20, 2009
Skin Tightening - American Health and Beauty - American Health and Beauty - Mesotherapy Thermage Liposuction... - Feb 7, 2007

Syneron Medical Ltd. discussions

  View all discussions »

Description

Syneron Medical Ltd. designs, develops and markets medical products based on its various technologies including its Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy. The Company’s products focus on an array of non-invasive medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skin’s appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin and laser-assisted lipolysis. The Company’s subsidiaries include Syneron GmbH, Syneron Inc., Syneron Canada Corp., Syneron Medical (HK) Ltd.

Officers and directors

Shimon Eckhouse
Chairman of the Board
Age: 64
Bio & Compensation - Reuters
Louis P. Scafuri
Chief Executive Officer
Age: 57
Bio & Compensation - Reuters
Fabian Tenenbaum
Chief Financial Officer
Age: 35
Bio & Compensation - Reuters
David Schlachet
Director
Age: 64
Bio & Compensation - Reuters
Marshall Butler
Director
Age: 82
Bio & Compensation - Reuters
Dan S. Suesskind
External Director
Age: 65
Bio & Compensation - Reuters
Michael J. Anghel
External Director
Age: 70
Bio & Compensation - Reuters
Yaffa Krindel
Director
Age: 54
Bio & Compensation - Reuters